HPV52 is a high-risk human papillomavirus, which may cause cervical cancer or cervical intraepithelial neoplasia if the infection persists for less than two years. Clinical treatment depends on the duration of HPV52 positivity. Most HPV52 positives may turn negative naturally and do not require special treatment. If HPV52 is persistently positive or combined with TCT changes, aggressive treatment should be given.